Cloning and variation of ground state intestinal stem cells (original) (raw)

Accession codes

Primary accessions

European Nucleotide Archive

Gene Expression Omnibus

Data deposits

Data sets generated for this study have been submitted to the National Center for Biotechnology Information Gene Expression Omnibus (GEO) database and the European Nucleotide Archive under accession numbers GSE66749 and SRP056402.

References

  1. Tabar, V. & Studer, L. Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nature Rev. Genet. 15, 82–92 (2014)
    Article CAS PubMed Google Scholar
  2. Okano, H. & Yamanaka, S. iPS cell technologies: significance and applications to CNS regeneration and disease. Mol. Brain 7, 22 (2014)
    Article PubMed PubMed Central CAS Google Scholar
  3. Müller, A. M. & Dzierzak, E. A. ES cells have only a limited lymphopoietic potential after adoptive transfer into mouse recipients. Development 118, 1343–1351 (1993)
    Article PubMed Google Scholar
  4. Helgason, C. D., Sauvageau, G., Lawrence, H. J., Largman, C. & Humphries, R. K. Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro. Blood 87, 2740–2749 (1996)
    Article CAS PubMed Google Scholar
  5. Bonde, S., Dowden, A. M., Chan, K. M., Tabayoyong, W. B. & Zavazava, N. HOXB4 but not BMP4 confers self-renewal properties to ES-derived hematopoietic progenitor cells. Transplantation 86, 1803–1809 (2008)
    Article CAS PubMed PubMed Central Google Scholar
  6. Iuchi, S., Dabelsteen, S., Easley, K., Rheinwald, J. G. & Green, H. Immortalized keratinocyte lines derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA 103, 1792–1797 (2006)
    Article ADS CAS PubMed PubMed Central Google Scholar
  7. Amabile, G. et al. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood 121, 1255–1264 (2013)
    Article CAS PubMed PubMed Central Google Scholar
  8. Suzuki, N. et al. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol. Ther. 21, 1424–1431 (2013)
    Article CAS PubMed PubMed Central Google Scholar
  9. Rheinwatd, J. G. & Green, H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6, 331–343 (1975)
    Article Google Scholar
  10. Rama, P. et al. Limbal stem-cell therapy and long-term corneal regeneration. N. Engl. J. Med. 363, 147–155 (2010)
    Article CAS PubMed Google Scholar
  11. Senoo, M., Pinto, F., Crum, C. P. & McKeon, F. p63 is essential for the proliferative potential of stem cells of stratified epithelia. Cell 129, 523–536 (2007)
    Article CAS PubMed Google Scholar
  12. Kumar, P. A. et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 147, 525–538 (2011)
    Article CAS PubMed PubMed Central Google Scholar
  13. Matsuura, R. et al. Crucial transcription factors in endoderm and embryonic gut development are expressed in gut-like structures from mouse ES cells. Stem Cells 24, 624–630 (2006)
    Article PubMed CAS Google Scholar
  14. Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262–265 (2009)
    Article ADS CAS PubMed Google Scholar
  15. Ootani, A. et al. Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche. Nature Med. 15, 701–706 (2009)
    Article CAS PubMed Google Scholar
  16. Sato, T. et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469, 415–418 (2011)
    Article ADS CAS PubMed Google Scholar
  17. Fordham, R. P. et al. Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury. Cell Stem Cell 13, 734–744 (2013)
    Article CAS PubMed PubMed Central Google Scholar
  18. Middendorp, S. et al. Adult stem cells in the small intestine are intrinsically programmed with their location-specific function. Stem Cells 32, 1083–1091 (2014)
    Article CAS PubMed Google Scholar
  19. Yin, X. et al. Niche-independent high-purity cultures of Lgr5+ intestinal stem cells and their progeny. Nature Methods 11, 106–112 (2014)
    Article CAS PubMed Google Scholar
  20. Kim, K. A. et al. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 309, 1256–1259 (2005)
    Article ADS CAS PubMed Google Scholar
  21. Dreesen, O. & Brivanlou, A. H. Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev. 3, 7–17 (2007)
    Article CAS PubMed Google Scholar
  22. Zhu, L. et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457, 603–607 (2009)
    Article ADS CAS PubMed Google Scholar
  23. Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003–1007 (2007)
    Article ADS CAS PubMed Google Scholar
  24. Powell, A. E. et al. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149, 146–158 (2012)
    Article CAS PubMed PubMed Central Google Scholar
  25. Botrugno, O. A. et al. Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol. Cell 15, 499–509 (2004)
    Article CAS PubMed Google Scholar
  26. Lessard, J. & Sauvageau, G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255–260 (2003)
    Article ADS CAS PubMed Google Scholar
  27. Sangiorgi, E. & Capecchi, M. R. Bmi1 is expressed in vivo in intestinal stem cells. Nature Genet. 40, 915–920 (2008)
    Article CAS PubMed Google Scholar
  28. Tian, H. et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 478, 255–259 (2011)
    Article ADS CAS PubMed PubMed Central Google Scholar
  29. Metcalfe, C., Kljavin, N. M., Ybarra, R. & de Sauvage, F. J. Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration. Cell Stem Cell 14, 149–159 (2014)
    Article CAS PubMed Google Scholar
  30. Battle, M. A. et al. GATA4 is essential for jejunal function in mice. Gastroenterology 135, 1676–1686 (2008)
    Article CAS PubMed Google Scholar
  31. Walker, E. M., Thompson, C. A. & Battle, M. A. GATA4 and GATA6 regulate intestinal epithelial cytodifferentiation during development. Dev. Biol. 392, 283–294 (2014)
    Article CAS PubMed PubMed Central Google Scholar
  32. Dusing, M. R., Maier, E. A., Aronow, B. J. & Wiginton, D. A. Onecut-2 knockout mice fail to thrive during early postnatal period and have altered patterns of gene expression in small intestine. Physiol. Genomics 42, 115–125 (2010)
    Article CAS PubMed PubMed Central Google Scholar
  33. International Stem Cell Initiative. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nature Biotechnol. 29, 1132–1144 (2011)
  34. Avery, S. et al. BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures. Stem Cell Rep. 1, 379–386 (2013)
    Article CAS Google Scholar
  35. Shultz, L. D. et al. Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harb Protoc. http://dx.doi.org/10.1101/pdb.top073585 (2014)
  36. Voth, D. E. & Ballard, J. D. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18, 247–263 (2005)
    Article CAS PubMed PubMed Central Google Scholar
  37. Carter, G. P., Rood, J. I. & Lyras, D. The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol. 20, 21–29 (2012)
    Article CAS PubMed Google Scholar
  38. Lyras, D. et al. Toxin B is essential for virulence of Clostridium difficile. Nature 458, 1176–1179 (2009)
    Article ADS CAS PubMed PubMed Central Google Scholar
  39. Farrow, M. A. et al. Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex. Proc. Natl Acad. Sci. USA 110, 18674–18679 (2013)
    Article ADS CAS PubMed PubMed Central Google Scholar
  40. Huelsenbeck, J. et al. Upregulation of the immediate early gene product RhoB by exoenzyme C3 from Clostridium limosum and toxin B from Clostridium difficile. Biochemistry 46, 4923–4931 (2007)
    Article CAS PubMed Google Scholar
  41. Aktories, K., Schmidt, G. & Just, I. Rho GTPases as targets of bacterial protein toxins. Biol. Chem. 381, 421–426 (2000)
    Article CAS PubMed Google Scholar
  42. MacFie, T. S. et al. DUOX2 and DUOXA2 form the predominant enzyme system capable of producing the reactive oxygen species H2O2 in active ulcerative colitis and are modulated by 5-aminosalicylic acid. Inflamm. Bowel Dis. 20, 514–524 (2014)
    Article PubMed Google Scholar
  43. Cheng, H. & Leblond, C. P. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am. J. Anat. 141, 537–561 (1974)
    Article CAS PubMed Google Scholar
  44. Yui, S. et al. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell. Nature Med. 18, 618–623 (2012)
    Article CAS PubMed Google Scholar
  45. Wang, F. et al. Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay. Gastroenterology 145, 383–395 (2013)
    Article CAS PubMed Google Scholar
  46. Watson, C. L. et al. An in vivo model of human small intestine using pluripotent stem cells. Nature Med. 20, 1310–1314 (2014)
    Article CAS PubMed Google Scholar
  47. Sheaffer, K. L. & Kaestner, K. H. Transcriptional networks in liver and intestinal development. Cold Spring Harb. Perspect. Biol. 4, a008284 (2012)
    Article PubMed PubMed Central CAS Google Scholar
  48. Nicholson, J. K. et al. Host-gut microbiota metabolic interactions. Science 336, 1262–1267 (2012)
    Article ADS CAS PubMed Google Scholar
  49. Brandl, K. & Beutler, B. Creating diseases to understand what prevents them: genetic analysis of inflammation in the gastrointestinal tract. Curr. Opin. Immunol. 24, 678–685 (2012)
    Article CAS PubMed PubMed Central Google Scholar
  50. Lees, C. W., Barrett, J. C., Parkes, M. & Satsangi, J. New IBD genetics: common pathways with other diseases. Gut 60, 1739–1753 (2011)
    Article CAS PubMed Google Scholar
  51. Schmidt, D., Hübsch, U., Wurzer, H., Heppt, W. & Aufderheide, M. Development of an in vitro human nasal epithelial (HNE) cell model. Toxicol. Lett. 88, 75–79 (1996)
    Article CAS PubMed Google Scholar
  52. Chumbler, N. M. et al. Clostridium difficile toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism. PLoS Pathog. 8, e1003072 (2012)
    Article CAS PubMed PubMed Central Google Scholar
  53. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005)
    Article ADS CAS PubMed PubMed Central Google Scholar
  54. Wang, K. et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 17, 1665–1674 (2007)
    Article CAS PubMed PubMed Central Google Scholar
  55. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler Transform. Bioinformatics 25, 1754–1760 (2009)
    Article CAS PubMed PubMed Central Google Scholar
  56. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010)
    Article CAS PubMed PubMed Central Google Scholar
  57. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009)
    Article PubMed PubMed Central Google Scholar
  58. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010)
    Article PubMed PubMed Central CAS Google Scholar

Download references

Acknowledgements

This work was supported by grants from Connecticut Innovations (W.X., F.M.), the Joint Council Office of the Agency for Science Technology Research Agency (A*STAR), Singapore (W.X., F.M.), the National Medical Research Council, Singapore (BNB101677A to H.K.Y., F.M., and W.X.; BnB11dec063 to N.N., F.M. and W.X.), the Department of Defense (W81XWH-10-1-0289 to C.P.C.) and the National Institute of Health (AI09575504 to D.B.L.). We thank M. LaLande, B. Lane and B. Seet for support, B. Tennent, B. Knowles and T. McLaughlin for comments on the manuscript, J. Hammer for artwork, L. Lapierre and J. Franklin for histology evaluation. We thank H. Green for advice and support.

Author information

Author notes

  1. Xia Wang and Yusuke Yamamoto: These authors contributed equally to this work.

Authors and Affiliations

  1. The Jackson Laboratory for Genomic Medicine, Farmington, 06032, Connecticut, USA
    Xia Wang, Yusuke Yamamoto, Lane H. Wilson, Gang Ning, Yue Hong, Benoit Chevalier, Frank McKeon & Wa Xian
  2. Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, 06032, Connecticut, USA
    Lane H. Wilson & Wa Xian
  3. Genome Institute of Singapore, Agency for Science, Technology and Research, 138672, Singapore
    Ting Zhang, Florian Kern, Chiea Chuen Khor, Denis Bertrand, Lingyan Wu, Niranjan Nagarajan & Frank McKeon
  4. Department of Pathology, Brigham and Women's Hospital, Boston, 02118, Massachusetts, USA
    Brooke E. Howitt, Christopher P. Crum & Wa Xian
  5. Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, 37232, Tennessee, USA
    Melissa A. Farrow & D. Borden Lacy
  6. Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, 119228, Singapore
    Chiea Chuen Khor
  7. Department of Pediatrics, Division of Gastroenterology, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, North Carolina, USA
    Francisco A. Sylvester
  8. Division of Digestive Diseases, Hepatology, and Nutrition, Connecticut Children's Medical Center, Hartford, 06106, Connecticut, USA
    Jeffrey S. Hyams
  9. Department of Medicine, University of Connecticut Health Center, Farmington, 06032, Connecticut, USA
    Thomas Devers
  10. Department of Microbiology and Immunobiology, Harvard Medical School, Boston, 02115, Massachusetts, USA
    Roderick Bronson
  11. Department of Medicine, National University of Singapore, 119228, Singapore
    Khek Yu Ho, Frank McKeon & Wa Xian
  12. Multiclonal Therapeutics, Inc., Farmington, 06032, Connecticut, USA
    Frank McKeon & Wa Xian

Authors

  1. Xia Wang
  2. Yusuke Yamamoto
  3. Lane H. Wilson
  4. Ting Zhang
  5. Brooke E. Howitt
  6. Melissa A. Farrow
  7. Florian Kern
  8. Gang Ning
  9. Yue Hong
  10. Chiea Chuen Khor
  11. Benoit Chevalier
  12. Denis Bertrand
  13. Lingyan Wu
  14. Niranjan Nagarajan
  15. Francisco A. Sylvester
  16. Jeffrey S. Hyams
  17. Thomas Devers
  18. Roderick Bronson
  19. D. Borden Lacy
  20. Khek Yu Ho
  21. Christopher P. Crum
  22. Frank McKeon
  23. Wa Xian

Contributions

Experimental design and conception were done by W.X., F.M., D.B.L., K.Y.H. and C.P.C.; X.W. cloned and differentiated the intestinal stem cells with help from L.H.W., F.K., G.N., B.E.H. and Y.H.; Y.Y., X.W. prepared the genomic and gene expression analyses together with F.K., G.N., C.C.K. and L.W.; T.Z., D.B. and N.N. performed all computational and bioinformatics work. B.H. and C.P.C. obtained fetal tissues and F.A.S., J.S.H. and T.D. provided endoscopic biopsies, and R.B. analysed the xenografts. The C. difficile experiments were designed and executed by B.C., L.H.W., M.A.F. and D.B.L.; W.X. and F.M. wrote the manuscript with input from all other authors.

Corresponding authors

Correspondence toFrank McKeon or Wa Xian.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Extended data figures and tables

Extended Data Figure 1 Loss of clonogenicity in differentiated ISC.

a, Schematic of ISC differentiation using either the γ-secretase inhibitor dibenzazepine (DBZ) or withdrawal of the Wnt regulator R-spondin 1 (Rspo1). ISCs were plated on day 0, DBZ added or Rspo1 removed at day 2, and colonies passaged en masse at day 7. At day 14, after 7 days of continuous growth, colonies were counted. b, Micrographs show immunofluorescence at day 7 colonies grown without Rspo1 or in the presence of DBZ for 5 days using antibodies to Ki67, chromogranin A (CHGA), keratin 20 (Krt20), E-cadherin (E-cad), and mucin 2 (Muc2). Scale bar, 50 μm; n = 4 technical replicates. c, Histogram shows colony formation in each condition normalized to control ISCs. n = 4 biological replicates; error bars, s.d. d, Staining of ALI-differentiated intestinal stem cells with monoclonal antibody HD6 directed to Paneth cells. Scale bar, 50 μm; n = 4 technical replicates.

Extended Data Figure 2 Intestinal stem cell expression profiles.

a, List of genes differentially expressed in ISC derived from duodenum, jejunum and ileum. These data correspond to heat map of Fig. 2b. b, Immunofluorescence labelling of ALI-differentiated ISCs from duodenum with antibodies against Tff2, mucin 5AC, villin, E-cadherin, and mucin 2. c, Immunofluorescence labelling of ALI-differentiated epithelia from jejunum stem cells with antibodies to E-cadherin, mucin 2, villin, and mucin 5AC. Scale bar, 50 μm; n = 10 technical replicates.

Extended Data Figure 3 Differential gene expression in epithelia derived from colonic stem cells.

Heat map of differentially expressed (>1.5-fold, P < 0.05) genes in ALI cultures derived from stem cell pedigrees of ascending, transverse, and descending colon.

Extended Data Figure 4 Differential gene expression across columnar and stratified epithelial stem cells.

a, Histograms of expression microarray signal intensity of selected genes across averaged intestine and colon ISCs, stratified epithelial stem cells, and stem cells of the fallopian tube (FT). Biological replicas n = 2–6 (FT = 2, stratified epithelia = 3, colon, intestine = 6); error bars, s.d. b, Dot plot showing expression microarray data of indicated genes for stem cell pedigrees (ISC; Duo, duodenum; Jej, jejunum; Ile, ileum; AC, ascending colon; TC, transverse colon; DC, descending colon) derived from various regions of the intestinal tract before and after air–liquid interface (ALI) differentiation. Biological replicas n = 2 (total 12 data sets) for stem cells, technical replicas n = 2 for ALI. c, Chart of aggregate P values by Student's _t_-test for gene expression changes between ground state stem cells and their ALI-differentiated counterparts.

Extended Data Figure 5 Genes affected by CNV and SNV events in intestinal stem cell pedigrees during passaging.

a, Summary of CNV (events (genes affected)) and non-synonymous SNV in pedigrees 1 and 2 at P5 to P20. b, Summary of genes altered by interstitial CNV amplifications (top) or deletions (bottom) in ISC pedigrees 3 to 7 at P5 and P25. c, Summary of genes sustaining non-synonymous SNV in five ISC pedigrees at P5 and P25.

Extended Data Figure 7 Impact of ISC_GS_ passaging on ALI differentiation.

ALI differentiation of intestinal pedigree 2 initiated from cells at the indicated passage number. As indicated, histological sections of differentiated epithelia were stained with antibodies to either E-cadherin (ECAD, green) and mucin 2 (Muc2, red), or Ki67 (green) and chromogranin A (CHGA, red). Scale bar, 75 μm; n = 4 technical replicates.

Extended Data Figure 8 ISCGS tumorigenicity assays in immunodeficient mice.

a, Quantification of tumour formation assessments at 4–16 weeks following subcutaneous inoculation of two million cells of the indicated ISC pedigrees at passage 6 or passage 25 at 4–16 weeks. ‘Pool’ indicates total set of clones derived from P0 ileum culture before pedigree generation. ‘Cancer cells’ refers to propagating cells from case of high-grade serous ovarian cancer. b, Left, histological section through site of injection of 1 million cells from pedigree 3. Right, section of injection site stained with antibody (STEM121) to human epithelial cells (brown) revealing benign cysts. Scale bar, 15 μm.

Extended Data Figure 9 Dose- and time-dependency of TcdB pathology in ALI-generated colonic epithelia.

a, Immunofluorescence localization of adherens junction marker E-cadherin and tight junction marker claudin 3 in ALI-differentiated epithelia derived from transverse colon stem cells following exposure to 100 pM TcdB for the indicated durations. n = 4 technical replicates. Scale bar, 100 μm. b, Representative H&E images of ALI cultures at indicated times and concentration of TcdB exposure. Scale bar, 250 μm; n = 4 technical replicates. c, Gene set enrichment analysis of whole-genome expression data from colonic epithelia treated with 500pM TcdB for 24 h and control samples showing enriched KEGG pathway sets. NES, normalized enrichment score; NOM P value, nominal P value. d, 3D plot of upregulated genes at the indicated time points and dosages > twofold, P < 0.05). _n_ = 2 technical replicates. **e**, Heat map of upregulated genes in 500 pM TcdB samples. The genes (237 genes) were chosen by cutoff values (> twofold, P < 0.05). Three time points (8, 16 and 24 h) are shown. **f**, 3D plot of downregulated genes at the indicated time points and dosages > twofold, P < 0.05). n = 2 technical replicates.

Extended Data Figure 10 Dose- and time-dependency of TcdA pathology in ALI-generated colonic epithelia.

a, Left, representative H&E images of ALI cultures at indicated times and concentration of TcdA exposure; right, immunofluorescence localization of adherens junction marker E-cadherin (ECAD; green) and mucin 2 (MUC2; red) in ALI-differentiated epithelia derived from transverse colon stem cells following incubation with 10 nM TcdA for the indicated durations. Scale bar, 100 μm; n = 4 technical replicates. b, 3D plot of histological scoring of representative H&E time points and concentrations performed by a gastrointestinal pathologist according to a standard 0–3 rating for colonic epithelial integrity. c, Distribution of tight junction marker claudin 3 (Cldn3) and adherens junction marker (Cdh17) following treatment of ALI colonic epithelium with TcdA for the indicated times and doses. Scale bar, 50 μm; n = 4 technical replicates. d, Histogram of permeability of ALI colonic epithelium (Papp) to small molecules (FD4, molecular mass 4,400 Da) following exposure to the indicated doses of TcdA for the indicated times.

Supplementary information

Supplementary Tables

This file contains Supplementary Tables 1-3 and a further table containing a summary of CNV and exome capture sequencing run analysis for intestinal stem cells. (PDF 334 kb)

PowerPoint slides

Source data

Rights and permissions

About this article

Cite this article

Wang, X., Yamamoto, Y., Wilson, L. et al. Cloning and variation of ground state intestinal stem cells.Nature 522, 173–178 (2015). https://doi.org/10.1038/nature14484

Download citation